PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Symptom | C0020542|pulmonary hypertension |
| Sentences | 109 |
| PubMedID- 23829793 | Group 2 'pulmonary hypertension due to left heart diseases' is divided into three sub-groups: systolic dysfonction, diastolic dysfonction and valvular dysfonction. |
| PubMedID- 25453535 | The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. |
| PubMedID- 24987253 | The clinical characteristics of the study population including the referral diagnosis are listed in table 1. ventricular septal defect (vsd) was the most common congenital heart disease leading to pulmonary hypertension in this study. |
| PubMedID- 20196994 | pulmonary hypertension due to left heart disease is a pathophysiological and hemodynamic state which is present in a wide range of clinical conditions that affect left heart structures. |
| PubMedID- 26262457 | Purpose of review: pulmonary hypertension associated with left heart disease is the most commonly encountered form of pulmonary hypertension and is associated with a poor prognosis. |
| PubMedID- 25705389 | Current classification describes five main groups with shared clinical and pathophysiological characteristics (figure 1): group 1, pah; group 2, pulmonary hypertension associated with left heart disease; group 3, pulmonary hypertension associated with lung disease; group 4, chronic thromboembolic pulmonary hypertension (cteph); and group 5, miscellaneous with unclear mechanisms 2. |
| PubMedID- 22884380 | pulmonary hypertension associated with left heart disease is the most common form of pulmonary hypertension encountered in clinical practice today. |
| PubMedID- 23258775 | High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. |
| PubMedID- 25006452 | Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures. |
| PubMedID- 21191432 | pulmonary hypertension due to left-sided heart disease, hypoxemic lung disease, and thromboembolic disorders are each classified separately. |
| PubMedID- 24460475 | Objectives: pulmonary hypertension (ph) due to left heart disease may impair outcome after heart transplantation (ht). |
| PubMedID- 22494051 | Quantitative evaluation of right ventricle function by transthoracic echocardiography in childhood congenital heart disease patients with pulmonary hypertension. |
| PubMedID- 21769595 | Perioperative management of pulmonary hypertension in children with critical heart disease. |
| PubMedID- 25076997 | Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: pulmonary hypertension due to left heart disease. |
| PubMedID- 25672044 | Enlargement of right atrium is usually secondary to pulmonary hypertension due to valvular heart diseases or obstructive pulmonary disorders, atrial septal defect, tricuspid atresia or stenosis, pulmonary stenosis, primary pulmonary hypertension, ebstein's anomaly. |
| PubMedID- 20646483 | Surgical treatment strategies for congenital heart disease with pulmonary hypertension. |
| PubMedID- 24081196 | The effects of perioperative inhaled iloprost on pulmonary hypertension with congenital heart disease. |
| PubMedID- 21875514 | pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies. |
| PubMedID- 20450852 | In addition, it contains detailed descriptions of the treatment recommended for patients in whom an elevated systolic pulmonary pressure is discovered on echocardiography, of the differential diagnosis of pulmonary arterial hypertension and pulmonary hypertension associated with left heart disease, and of multifactorial approaches to determining prognosis, which are three of the most actively debated topics today. |
| PubMedID- 25535690 | The aim of this study was to determine whether baseline characteristics and clinical events associate with mortality in patients with pulmonary hypertension (pah) due to congenital heart disease (chd). |
| PubMedID- 26502478 | The most common cause of ph, termed group 2 ph, is left-sided heart failure and is commonly known as pulmonary hypertension with left heart disease (ph-lhd). |
| PubMedID- 23592742 | pulmonary hypertension (ph) due to left heart disease is classified as group ii according to the dana point classification, which includes left ventricular systolic and/or diastolic left heart failure, and left-sided valvular disease. |
| PubMedID- 23098893 | We investigated the occurrence of bmpr2 mutation and genetic polymorphisms in children with pulmonary hypertension associated with congenital heart disease (aph/chd) and correlated with the pulmonary haemodynamic and vasoreactivity. |
| PubMedID- 26559982 | Palliative senning in the treatment of congenital heart disease with severe pulmonary hypertension. |
| PubMedID- 25721948 | Introduction: pulmonary hypertension (ph) due to left-sided heart disease (group 2 ph) is most commonly due to passive backward transmission of elevated left-sided heart pressures. |
| PubMedID- 24621657 | Background: pulmonary hypertension (ph) because of left-sided heart disease carries a poor prognosis. |
| PubMedID- 22837856 | enlargement of the right heart chambers, tricuspid regurgitation as a result of this chamber enlargement, flattening or paradoxical motion of the interventricular septum, encroachment of an enlarged right ventricle on the left ventricular cavity, and impaired left ventricular diastolic dysfunction not the result of primary left ventricular or valvular heart disease are findings in patients with significant pulmonary hypertension. |
| PubMedID- 24355634 | pulmonary hypertension due to left heart diseases. |
| PubMedID- 26232475 | Pulmonary arterial hypertension or left heart disease with pulmonary hypertension. |
| PubMedID- 20819756 | Increased resistance to pulmonary venous drainage is the main mechanism in pulmonary hypertension (ph) developing due to left heart disease. |
| PubMedID- 26299611 | pulmonary hypertension due to left heart disease: the prognostic implications of diastolic pulmonary vascular pressure gradient. |
| PubMedID- 25650280 | pulmonary hypertension associated with congenital heart disease and eisenmenger syndrome. |
| PubMedID- 25164216 | Research progress of pulmonary hypertension due to left heart disease. |
| PubMedID- 24039255 | Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease. |
| PubMedID- 25089008 | Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated nt-probnp levels or overt cardiac fibrosis but associated with increased levels of mr-proanp and mr-proadm: retrospective analysis of a french canadian cohort. |
| PubMedID- 24566553 | Objective: to investigate preoperative and postoperative blood levels of soluble intercellular and vascular cell adhesion molecules (sicam-1, svcam-1) in patients with and without pulmonary hypertension (pah) due to congenital heart disease and left to right (l-r) shunt and to determine whether these molecules can be used as reliable prognostic markers of endothelial activity to predict surgical outcomes. |
| PubMedID- 20592995 | Advanced valvular heart disease with secondary pulmonary hypertension due to impaired diastolic and/or systolic function of the left ventricle may support the occurrence of csa. |
| PubMedID- 20136857 | The object of this study is to determine the tolerability of a directed exercise program in congenital heart disease patients with pulmonary hypertension. |
| PubMedID- 24936542 | Objective: to investigate preoperative and postoperative blood levels of soluble intercellular and vascular cell adhesion molecules (sicam-1, svcam-1) in patients with and without pulmonary hypertension (pah) due to congenital heart disease and left to right (l-r) shunt and to determine whether these molecules can be used as reliable prognostic markers of endothelial activity to predict surgical outcomes. |
| PubMedID- 20522580 | pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. |
| PubMedID- 22221972 | pulmonary hypertension due to left heart disease: updated recommendations of the cologne consensus conference 2011. |
| PubMedID- 24075485 | Background: pulmonary hypertension associated with congenital heart disease increases the risk of surgery using cardiopulmonary bypass. |
| PubMedID- 23918108 | World health organization (who) group 2 pulmonary hypertension (ph) due to left-side heart disease (ie, heart failure or left-sided valvular heart disease) is the most common form of ph in western countries. |
| PubMedID- 20515628 | In patients with pulmonary hypertension due to left heart disease or lung disease, treatment focuses on the underlying condition and there is no convincing evidence that agents approved for pulmonary arterial hypertension are effective. |
| PubMedID- 24019248 | We report the clinical and histological findings and discuss about the impact of this unexpected and not-previously described associated lesion on the prognosis and on the therapeutic strategy in patients with pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 26202179 | There is no cure for pulmonary hypertension due to left heart disease (ph-lhd), but the rationale for using sildenafil to treat pulmonary arterial hypertension with heart failure with reduced ejection fraction (hfref) has been supported by short-term studies. |
| PubMedID- 25840093 | Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases. |
| PubMedID- 23129906 | Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease. |
| PubMedID- 23075130 | pulmonary hypertension associated with congenital heart disease: a practical review for the pediatric cardiologist. |
| PubMedID- 22360031 | Objectives: to evaluate the safety of valve replacement surgery in rheumatic heart disease patients with severe pulmonary hypertension (sph); defined as pulmonary artery systolic pressure (pasp > or = 60 mmhg) on patients operated for valve replacement at tabba heart institute, karachi. |